Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.69B |
| 2 |
Abbott
ABT
|
+$3.65B |
| 3 |
Qualcomm
QCOM
|
+$3.54B |
| 4 |
Procter & Gamble
PG
|
+$3.42B |
| 5 |
Accenture
ACN
|
+$3.28B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$2.86B |
| 2 |
AbbVie
ABBV
|
+$2.71B |
| 3 |
Valero Energy
VLO
|
+$1.86B |
| 4 |
Lockheed Martin
LMT
|
+$916M |
| 5 |
Halliburton
HAL
|
+$856M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 10.68% |
| 3 | Healthcare | 10.19% |
| 4 | Industrials | 8.63% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PONY
2601
Pony AI Inc
PONY
$3.1B
| $2.98M | ﹤0.01% |
+315,915
| New | +$4.35M |
|
2602
Cerus
CERS
$587M
| $2.97M | ﹤0.01% |
1,630,069
-36,859
| -2% | -$80.3K |
|
2603
Angi Inc
ANGI
$224M
| $2.95M | ﹤0.01% |
430,675
+52,938
| +14% | +$531K |
|
2604
Arhaus
ARHS
$1.12B
| $2.95M | ﹤0.01% |
434,445
-10,950
| -2% | -$99.4K |
|
|
JCAP
2605
Jefferson Capital
JCAP
$1.22B
| $2.94M | ﹤0.01% |
152,999
+75,187
| +97% | +$1.59M |
|
2606
United States Antimony
UAMY
$766M
| $2.94M | ﹤0.01% |
336,733
-32,729
| -9% | -$285K |
|
|
OLP
2607
One Liberty Properties
OLP
$548M
| $2.93M | ﹤0.01% |
136,643
-176
| -0.1% | -$3.91K |
|
2608
Granite Ridge Resources
GRNT
$640M
| $2.93M | ﹤0.01% |
499,140
+2,978
| +0.6% | +$14.9K |
|
|
BULL
2609
Webull Corp
BULL
$3.98B
| $2.91M | ﹤0.01% |
606,700
-71,115
| -10% | -$461K |
|
2610
James Hardie Industries
JHX
$15.4B
| $2.91M | ﹤0.01% |
153,723
+110,441
| +255% | +$2.48M |
|
|
AKTS
2611
Aktis Oncology
AKTS
$1.32B
| $2.9M | ﹤0.01% |
+162,017
| New | +$3.15M |
|
2612
Hamilton Insurance Group
HG
$3.59B
| $2.89M | ﹤0.01% |
96,908
-14,929
| -13% | -$430K |
|
2613
Agilon Health
AGL
$1.64B
| $2.88M | ﹤0.01% |
364,499
+43,739
| +14% | +$707K |
|
2614
Canadian Solar
CSIQ
$906M
| $2.88M | ﹤0.01% |
207,853
-9,547
| -4% | -$182K |
|
|
MH
2615
McGraw Hill
MH
$1.9B
| $2.88M | ﹤0.01% |
210,087
-6,232
| -3% | -$87.5K |
|
2616
Wolfspeed
WOLF
$1.2B
| $2.87M | ﹤0.01% |
175,796
+115,118
| +190% | +$2.08M |
|
|
PVLA
2617
Palvella Therapeutics
PVLA
$1.98B
| $2.86M | ﹤0.01% |
22,970
+1,337
| +6% | +$139K |
|
2618
Blend Labs
BLND
$409M
| $2.82M | ﹤0.01% |
1,660,571
-148,695
| -8% | -$318K |
|
2619
Sprout Social
SPT
$455M
| $2.82M | ﹤0.01% |
494,552
-12,402
| -2% | -$95.5K |
|
2620
Yext
YEXT
$501M
| $2.81M | ﹤0.01% |
732,393
-251,192
| -26% | -$1.51M |
|
2621
Maravai LifeSciences
MRVI
$997M
| $2.81M | ﹤0.01% |
993,348
+5,308
| +0.5% | +$18K |
|
2622
Akebia Therapeutics
AKBA
$327M
| $2.8M | ﹤0.01% |
2,015,577
-165,243
| -8% | -$227K |
|
2623
Advantage Solutions
ADV
$484M
| $2.79M | ﹤0.01% |
131,848
-18,593
| -12% | -$358K |
|
2624
Gogo Inc
GOGO
$515M
| $2.77M | ﹤0.01% |
689,777
-10,245
| -1% | -$46.7K |
|
2625
Perspective Therapeutics
CATX
$332M
| $2.76M | ﹤0.01% |
661,318
+125,841
| +24% | +$532K |
|
Similar funds
Charles Schwab's Q1 2026 Portfolio in Review
As of Q1 2026, Charles Schwab held 3,535 positions worth $654B, up 1.7% from $644B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab deployed $21.4B of net new capital in Q1 2026, opening 79 new positions and adding to 1,903 existing holdings. Its largest new stake was JPMorgan Income ETF: 8,679,689 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $2.86B trimmed.
- Charles Schwab's largest Q1 2026 buy was JPMorgan Income ETF: 8,679,689 shares worth $400M.
- Charles Schwab added most to UnitedHealth in Q1 2026, an estimated $3.69B increase.
- Charles Schwab's biggest Q1 2026 reduction was Cisco, cutting an estimated $2.86B.
- Charles Schwab fully exited Comerica in Q1 2026, selling an estimated $412M.
- Charles Schwab's ten largest holdings make up 22% of its $654B portfolio in Q1 2026.
- Charles Schwab opened 79 new positions and closed 80 in Q1 2026.
- Charles Schwab's portfolio value rose 1.7% quarter-over-quarter to $654B.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.